Elevance Health Inc. (ELV) Stock

About Elevance Health Inc.

Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.

Elevance Health Inc. is led by CEO Gail Koziara Boudreaux, employs 104,200 people, headquartered in Indianapolis, US, publicly traded since 2001.

Elevance Health Inc. (ELV) stock trades at $375.98 with a market capitalization of $81.54B. The stock is valued at a price-to-earnings (P/E) ratio of 16.01, price-to-book of 1.87, price-to-sales of 0.43. Over the past 52 weeks the stock has ranged between $273.71 and $430.39, and currently trades 12.6% below its 52-week high. It pays a dividend yielding 1.72%.

On profitability, Elevance Health Inc. generates a return on equity (ROE) of 12.09%, above the typical market average, return on capital employed of 18.43%, an operating margin of 4.07%, a net profit margin of 2.62%.

In its most recent fiscal year, Elevance Health Inc. reported annual revenue of $199.1B, net profit of $5.7B, revenue has compounded at 10.3% a year over the last five years, profit at 4.4% a year.

The balance sheet shows a debt-to-equity ratio of 0.73, a current ratio of 1.24, total assets of $121.5B, $9.5B in cash and equivalents.

ELV has an average daily trading volume of 1,701,542 shares, a beta of 0.68 (less volatile than the overall market).

Official website: www.elevancehealth.com